secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001459839-23-000058
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q1 revenue $32.7M (+46% YoY), raises FY2023 guidance to $128-131M
-------------------------------------------------------------------------

- Record worldwide revenue $32.7M (+46% YoY); US revenue $30.5M (+50% YoY).
- Net loss improved to $11.1M ($0.32/diluted share) from $17.4M ($0.52) a year ago.
- Gross margin 82% (down from 87%) due to product mix, new implants, and higher freight/depreciation.
- FY2023 revenue guidance raised to $128-131M, implying 20-23% annual growth.
- Over 950 active US surgeons (+40% YoY); cash $86M, borrowings $35.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983923000058/0001459839-23-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983923000058/sibn-20230501.htm
  HTML page:      https://secwatch.observer/filing/0001459839-23-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer